Trials / Conditions / Myelodysplastic Neoplasm
Myelodysplastic Neoplasm
6 registered clinical trials studyying Myelodysplastic Neoplasm — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS NCT07532824 | Institute of Hematology and Blood Transfusion, Czech Republic | Phase 1 / Phase 2 |
| Recruiting | Oral-ATO for TP53-mutated Myeloid Malignancies NCT06778187 | The University of Hong Kong | Phase 2 |
| Withdrawn | Phase I/II Study of a Combination of Decitabine and Cedazuridine (ASTX727) and ASTX029, an ERK Inhibitor, for NCT06284460 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Withdrawn | Magrolimab Plus Intensive Chemotherapy in Newly Diagnosed AML or HR-MDS NCT05829434 | Uwe Platzbecker | Phase 2 |
| Recruiting | Intensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary Involvem NCT06111612 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | — |
| Recruiting | Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS NCT04741945 | Kirsten Grønbæk | Phase 2 |